Abstract
The release of prostaglandin E2 by human and Syrian hamster tumor cells in response to contact with natural killers and their sensitivity to cytostatic activity of natural killers were studied. A previously reported correlation between prostaglandin E2 release by Syrian hamster tumor cells and their resistance to cytostatic activity of natural killers was confirmed. This resistance can be cancelled by inhibition of prostaglandin E2 release with indomethacin. Unlike malignant tumor cells of Syrian hamsters, only few human tumor cells resistant to cytostatic activity of natural killers secrete prostaglandin E2. The resistance of these cell strains to cytostatic activity of natural killers could be cancelled by indomethacin treatment. Possible role of prostaglandin E2 release as a mechanism of tumor cell protection from effector cells of this type of natural (congenital) immunity is discussed.
Similar content being viewed by others
REFERENCES
G. I. Deichman, Biokhimiya, 65, No. 1, 112-126 (2000).
T. E. Klyuchareva, V. A. Matveeva, L. S. Bassalyk, and N. E. Kushlinskii, Byull. Eksp. Biol. Med., 105, No. 2, 204-206 (1988).
T. E. Klyuchareva, V. A. Matveeva, and E. N. Uvarova, Byull. Eksp. Biol. Med.., 110, No. 9, 308-310 (1990).
M. S. Brunda, R. B. Herberman, and H. T. Holden, Cell, 124, 2682-2687 (1979).
G. I. Deichman and E. L. Vendrov, Int. J. Cancer, 37, 401-409 (1986).
M. Droller, M. Schneider, and P. Perlmann, J. Immunol., 39, 165-177 (1979).
T. E. Klyuchareva, V. A. Matveeva, and N. E. Kushlinsky, Immunol. Lett., 33, 239-246 (1992).
C. Nathan, B. Arrick, H. Murray, et al., J. Exp. Med., 153, 76 (1981).
T. C. Timonen, W. Reynolds, I. R. Ortaldo, et al., J. Immunol. Methods, 51, 269-274 (1982).
M. R. Young and S. Knies, J. Natl. Cancer Inst., 72, 919-922 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matveeva, V.A. Prostaglandin E2 Release by Human and Syrian Hamster Tumor Cells and Their Sensitivity to Cytostatic Activity of Natural Killers. Bulletin of Experimental Biology and Medicine 131, 156–158 (2001). https://doi.org/10.1023/A:1017596029350
Issue Date:
DOI: https://doi.org/10.1023/A:1017596029350